Cargando…
Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells
BACKGROUND: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on this finding, we inve...
Autores principales: | Lin, Chiao-Wen, Chen, Pei-Ni, Chen, Mu-Kuan, Yang, Wei-En, Tang, Chih-Hsin, Yang, Shun-Fa, Hsieh, Yih-Shou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835430/ https://www.ncbi.nlm.nih.gov/pubmed/24278338 http://dx.doi.org/10.1371/journal.pone.0080883 |
Ejemplares similares
-
Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway
por: Chang, Chi-Wu, et al.
Publicado: (2014) -
Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression
por: Yang, Shih-Liang, et al.
Publicado: (2017) -
Kaempferol inhibits interleukin-1β stimulated matrix metalloproteinases by suppressing the MAPK-associated ERK and P38 signaling pathways
por: Huang, Xiaojian, et al.
Publicado: (2018) -
High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Hsin, Chung-Han, et al.
Publicado: (2014) -
Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression
por: Su, Chun-Wen, et al.
Publicado: (2017)